Advanced Prostate Cancer Cases Continue To Rise In Us | Latest News RSS Feed

Advanced Prostate Cancer Cases Continue To Rise In Us - Latest News


Advanced Prostate Cancer Cases Continue to Rise in U.S.

Coinciding with declines in prostate-specific antigen (PSA) screening over the last decade, the incidence of intermediate- and high-risk prostate cancer has continued to increase across the U.S. in ... read more

Add your link right here

Add your story here to improve SEO, search ranking and drive traffic to your website. Your link will be permanently featured right on this page. To add a link on diferent page, just visit the page you want to show your link and click "Add your link right here". You can use search form below to find the page. read more

Advanced Prostate Cancers Still Rising in US

The first study to report prostate cancer incidence up to and including 2016 shows that regional and metastatic disease continue to rise. read more

Cases of late-stage prostate cancer are on the rise as screenings decline

There's been a steady uptick in cases of men with late-stage prostate cancer, particularly in older ages, since the US recommended against screening. read more

Looking for another news?


'Alarming' rise in deadly prostate cancer cases as screening declines

Cases of advanced prostate cancer have increased among American men ages 50 and older, while cases of early-stage disease have declined, a study published Wednesday found. The study looked at cases ... read more


'Alarming' rise in possibly fatal prostate cancer as screening declines

The study looked at cases diagnosed between 2005 and 2016, during which time federal guidelines began recommending against prostate-specific antigen, or PSA, screening for prostate cancer detection ... read more

Doctors See Alarming Increase Of Prostate Cancer Cases As Screening Declines

An increasing number of cases of advanced prostate cancer was observed among American men aged 50 and over, according to a recently published study. read more

Clovis Oncology Announces Presentations at 2020 ASCO Virtual Scientific Program

Clovis Oncology, Inc. (NASDAQ: CLVS), announced today that six abstracts featuring data from clinical and real-world evidence studies evaluating Rubraca ® (rucaparib) in multiple tumor types have been ... read more

Cancer screenings dramatically declined due to COVID-19

Researchers estimate that tens of thousands of diagnoses for common cancers in the U.S. have been or will be missed or delayed, adding to the health challenges the coronavirus pandemic has inflicted ... read more

Coronavirus pandemic creates ‘many difficulties’ for cancer patients

COVID-9 is impacting the lives of cancer survivors in various ways. More than half of cancer survivors responding to a recent survey commissioned by the American Cancer Society Cancer Action Network ... read more

Stand up to Cancer hails FDA approval of olaparib for advanced prostate cancer

FDA-approved for patients with an aggressive form of prostate cancer, is a precision therapy that targets certain molecular qualities of advanced prostate cancer in patients with genetic mutations ... read more

Advanced prostate cancer incidence continued to increase after USPSTF recommendation on testing

Incidence of regional and distant-stage prostate cancer has continued to increase among men aged 50 years and older in the United States, according to results of a retrospective study published in ... read more

Coronavirus pandemic in the US

The US coronavirus outbreak has altered daily life in almost every way. Here's the latest updates on US Covid-19 cases, deaths, reopenings, the government response, unemployment and more. read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us